BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 903398)

  • 1. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
    Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
    J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
    Davies M; Taylor CM; Hill LF; Stanbury SW
    Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
    Kind HP; Prader A; DeLuca HF; Gugler E
    Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
    Hill LF; Davies M; Taylor CM; Standbury SW
    Clin Endocrinol (Oxf); 1976; 5 Suppl():167S-173S. PubMed ID: 1052776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoparathyroidism during pregnancy: treatment with calcitriol.
    Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism.
    Davies M
    Calcif Tissue Res; 1977 May; 22 Suppl():68-73. PubMed ID: 912592
    [No Abstract]   [Full Text] [Related]  

  • 9. 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
    Russell RG; Smith R; Walton RJ; Preston C; Basson R; Henderson RG; Norman AW
    Lancet; 1974 Jul; 2(7871):14-7. PubMed ID: 4134407
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of conventional doses of 1 alpha, 25-dihydroxycholecalciferol to correct hypocalcemia in a girl with idiopathic hypoparathyroidism.
    Chesney RW; Horowitz SD; Kream BE; Eisman JA; Hong R; DeLuca HF
    N Engl J Med; 1977 Dec; 297(23):1272-5. PubMed ID: 917074
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoparathyroidism and pregnancy. Treatment with calcitriol.
    Sadeghi-Nejad A; Wolfsdorf JI; Senior B
    JAMA; 1980 Jan; 243(3):254-5. PubMed ID: 7350374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: 1,25-Dihydroxycholecalciferol and 1 alpha-hydroxycholecalciferol in hypoparathyroidism.
    Parfitt AM
    Lancet; 1974 Aug; 2(7876):360. PubMed ID: 4136103
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infants.
    Senterre J; David L; Salle B
    Ann Endocrinol (Paris); 1979; 40(2):163-4. PubMed ID: 475308
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
    Henderson RG; Ledingham JG; Oliver DO; Small DG; Russell RG; Smith R; Walton RJ; Norman AW
    Clin Sci Mol Med; 1974 Feb; 46(2):10P. PubMed ID: 4817248
    [No Abstract]   [Full Text] [Related]  

  • 16. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommended for use in various bone diseases: therapy with a vitamin D metabolite].
    MMW Munch Med Wochenschr; 1979 Aug; 121(34):1062. PubMed ID: 114759
    [No Abstract]   [Full Text] [Related]  

  • 19. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
    Brickman AS; Coburn JW; Kurokawa K; Bethune JE; Harrison HE; Norman AW
    N Engl J Med; 1973 Sep; 289(10):495-8. PubMed ID: 4353218
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential use of 1,25-dihydroxycholecalciferol for prevention of parturient paresis.
    Gast DR; Horst RL; Jorgensen NA; DeLuca HF
    J Dairy Sci; 1979 Jun; 62(6):1009-13. PubMed ID: 500893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.